Appendix E
Contributors
This Appendix recognizes a number of individuals who contributed in various ways to this study who are not recognized in other sections of the report or appendixes. Many served on planning committees in the early stages of the project; whereas others contributed written materials, data, or provided testimony to the committee during the study. The committee wishes to extend their appreciation to all investigators and administrators who have contributed. The committee extends a special note of gratitude to Dr. Judith Vaitukaitis, now the Director of the National Center for Research Resources, without whose assistance this study could not have been performed. The provided herein reflects the contributor's position at the time of interaction with the committee.
WILLIAM B. ABRAMS, Executive Director, Scientific Development, Merck Sharp & Dohme Research, Laboratories, West Point, Pennsylvania
STEPHEN A. BARKANIC, Program Officer, Undergraduate Science Education Program, Howard Hughes Medical Institute, Bethesda, Maryland
J. CLAUDE BENNETT, Professor and Chairman, Department of Medicine, University of Alabama School of Medicine, Birmingham, Alabama
ROBERT BERLINER, Yale University School of Medicine, New Haven, Connecticut
BRUCE BRUNDAGE, Professor of Medicine and Chief of Cardiology, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois
LOUIS CANTILENA, Program Director, Division of Clinical Pharmacology, Uniformed Services University of Health Sciences, Bethesda, Maryland
SAM C. CARRIER, Provost, Oberlin College, Oberlin, Ohio
SEU LAIN CHEN, Division of Research Grants, National Institutes of Health, Bethesda, Maryland
DARYL CHUBIN, Senior Associate, U.S. Congress Office of Technology Assessment, Washington, D.C.
BARBARA FILNER, Program Officer, Graduate Science Education Program, Howard Hughes Medical Institute, Bethesda, Maryland
MARC S. GOLDSTEIN, Director, Research Services, American Physical Therapy Association, Alexandria, Virginia
RICHARD GREENE, Director, Center for Medical Effectiveness Research, Agency for Health Care Policy and Research, Rockville, Maryland
M. CAROLYN HARDEGREE, Director, Office of Biologics Research, Food and Drug Administration, Bethesda, Maryland
BERNADINE P. HEALY, Director, National Institutes of Health, Bethesda, Maryland
MARC HOROWITZ, Director, Loan Repayment Program, Office of AIDS Research, National Institutes of Health, Bethesda, Maryland
PAUL JOLLY, Associate Vice President, Section for Operational Studies, Association of American Medical Schools, Washington, D.C.
SHERRY KERAMIDAS, Associate Executive Vice President for Research and Education, American Physical Therapy Association, Alexandria, Virginia
CARL KUPFER, Director, National Eye Institute, National Institutes of Health, Bethesda, Maryland
JOHN LASZLO, American Cancer Society, Atlanta, Georgia
CLAUDE LENFANT, Director, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland
ROBERT MOORE, Division of Research Grants, National Institutes of Health, Bethesda, Maryland
ROBERT C. NELSON, Director, Office of Professional Development and Staff College, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Maryland
EDWARD H. O'NEIL, Director, Pew Health Professions Program, Duke University, Durham, North Carolina
CARL C. PECK, Director, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Maryland
JOHN T. POTTS, Jr., Professor and Chairman, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston Massachusetts.
THOMAS C. PURCELL, Director, Division of Training and Manpower Development, Centers for Disease Control, National Institute for Occupational Safety and Health, Cincinnati, Ohio
PAULA RANDOLPH, Elementary Teacher, Redmond School District, Redmond, Washington
MICHAEL ROSENBLATT, Senior Vice President for Research, Merck, Sharp & Dohme Laboratories, West Point, Pennsylvania
WALTER T. SCHAFFER, Research Training and Research Resources Officer, Office of Extramural Programs, National Institutes of Health, Bethesda, Maryland
ELAINE SEYMOUR, Bureau of Sociological Research, Department of Sociology, University of Colorado at Boulder, Boulder, Colorado
CHARLES SHERMAN, Office of Medical Applications of Research, National Institutes of Health, Bethesda, Maryland
LOUIS M. SHERWOOD, Executive Vice President, World Wide Development, Merck Sharp & Dohme Research Laboratories, Rahway, New Jersey
SAMUEL O. THIER, Former President, Institute of Medicine, National Academy of Sciences, Washington, D.C.
PHILIP TOSKES, University of Florida School of Medicine, Gainsville, Florida
JUDITH VAITUKAITIS, Deputy Director for Extramural Research Resources, National Center for Research Resources, National Institutes of Health, Bethesda, Maryland
DAVID DAVIS-VAN ATTA, Program Officer, Howard Hughes Medical Institute, Bethesda, Maryland
STEVEN WEISS, E. Gifford and Love Barnett Upjohn Professor of Internal Medicine and Oncology, University of Michigan Medical Center, Department of Internal Medicine, Division of Hematology/Oncology, Ann Arbor, Michigan
KERN WILDENTHAL, University of Texas Southwestern Medical Center, Dallas, Texas
ROGER L. WILLIAMS, Director, Office of Generic Drugs, Food and Drug Administration, Rockville, Maryland